AdvanCell Raises US$112 Million in Series C Funding
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, raised US$112 million in Series C financing. SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis co-led … Read more…